Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis

AimsTo explore the hepatoprotective role of quercetin and its novel molecular mechanism of action on breast cancer associated hepatic inflammation and fibrosis via Vitamin D receptor (VDR).Main methodsWe used Ehrlich Ascites Carcinoma (mouse mammary carcinoma) model for our in-vivo experiments and human breast cancer cell lines for in-vitro assays. We inoculated 1.5 × 106 Ehrlich ascites carcinoma cells into female Swiss albino mice. Quercetin (50 mg/kg) was administered intraperitoneally for 15 days. Liver enzymes activity was determined using a spectrophotometric assay. The hallmarks of inflammation and fibrosis were determined using Immunohistochemistry. The effect of quercetin on tumor formation was elucidated using human breast cancer cell lines and chick chorioallantoic membrane assay. Docking study was performed to explore the binding mode of quercetin with VDR.Key findingsIn EAC tumor-bearing mice, cell numbers, tumor volume, body weight and liver weight were dramatically increased, while they significantly decreased in mice treated with quercetin. Additionally, the peritoneal neo-angiogenesis was also significantly suppressed in the quercetin-treated mice, compared to the control. In addition, quercetin treated EAC tumor bearing mice had lower levels of liver enzymes, decreased hepatic inflammation and fibrosis compared with EAC tumor bearing mice. Docking study confirmed VDR-quercetin interaction. Furthermore, in-vitro assays and chick chorioallantoic membrane assay revealed the Vitamin D mimicking effect of quercetin.SignificanceDietary flavonoid, quercetin could act as a promising therapeutic drug to suppress the breast cancer induced tumor angiogenesis, hepatic inflammation, and fibrosis possibly via activation of VDR

Peregrination of endodontic tools-past to present

The clinical practice of yesterday′s endodontics becomes the heresy of today, and today′s endodontic practice becomes the heresy of tomorrow. The history of endodontics begins in the 17 th century. Since then, there have been numerous advances and developments, and research has proceeded continuously without pause. The manufacture of the first instruments for endodontic use dates back to 1875. These early instruments were made by hand from thin steel wires, and they performed the function of modern barbed broaches. In 1955, Ingle was the first to express the need for standardization of canal instruments. In 1965, the American Association of Endodontists adopted the terminology and nomenclature of the proposed standardized system. For many years, the standard cutting instruments have been the reamer, the K-type file, and the Hedstroem file. Recent changes in both metallurgy and endodontic concepts have led to the introduction of a wide range of new instruments. An effort has been made here to present the journey of endodontic instruments from the past to the present

Clinical considerations in restorative dentistry - A narrative review

The relationship between periodontal health and the restoration of teeth is intimate and inseparable. Human teeth are designed in such a way that the individual tooth contributes significantly to their own support as well as collectively the teeth in the arch. Decay on the proximal surfaces occurs mainly due to the faulty interrelationship between the contact area, marginal ridge, the embrasures and the gingiva. An adequate understanding of the relationship between periodontal tissues and restorative dentistry is paramount to ensure an adequate form, function, aesthetics and comfort of the dentition. For long-term survival of restoration, both functionally and esthetically, certain biological considerations are very critical to preserve the health of the periodontium and thus must be given due importance in clinical practice. While most clinicians are aware of this important relationship, uncertainly remains regarding specific concept such as biologic width and its maintainces

Effect of salivary contamination on shear bond strength of two adhesives: An in vitro study

Introduction: Composite material used with bonding system are technique sensitive and contamination of an etched surface by saliva or blood plays a key role in bonding efficacy. Achieving good moisture control is a common problem encountered and is of importance while treating a pediatric age group since rubber dam in dental office is commonly applied in fewer than 10% of restorative treatment. Despite the advantage of rubber dam application, usage of rubber dam depends on child′s behavior and its level of co-operation for which pediatric dentists compromise with its usage. This study was conducted to evaluate the effect of salivary contamination of enamel and dentin on bond strength of two adhesives. Materials and Methods: An in vitro study comprised of test group of 112 central incisors divided into 4 groups for testing on enamel and dentin separately. These are Group I: Control group without salivary contamination; Group II: Contaminated with saliva and air-dried; Group III: Contaminated with saliva, rinsed and air-dried; Group IV: Coated with adhesive, light cured and then contaminated. Shear bond strength was calculated using universal testing machine. Results: For testing on enamel and dentin, significantly decreased bond strength was seen with Group II (P < 0.05) and Group IV (P < 0.01) showed decreased bond strength, whereas bond strength of group III was not significant (P > 0.05), when compared with control Group I. Conclusion: The decontamination method used in this study by rinsing the contaminated cured adhesive layer that did not reverse the harmful effect of salivary contamination. As most of the children are active and restless with swinging mood, it is important not to negotiate with the procedural steps during treatment

Efficacy of NovaMin- and Pro-Argin-containing desensitizing dentifrices on occlusion of dentinal tubules

Introduction: Dentin hypersensitivity is a commonly occurring condition characterized by short, sharp pain arising from the exposed dentine in response to stimuli. Materials and Methods: Seventy extracted human permanent molars were selected and divided into four groups. The photomicrographs of the surface from the center of each dentinal block were obtained using a scanning electron microscope. The objective of this study was to evaluate the ability of three desensitizing dentifrices − SHY-NM (NovaMin), Sensitive Pro-Relief (8% arginine and calcium carbonate) and Thermoseal (10% strontium chloride) − for dentinal tubule occlusion using a scanning electron microscope. Results: All of the desensitizing dentifrices evaluated, SHY-NM showed the highest percentage of tubular occlusion (95.58%) followed by Sensitive Pro-Relief (89.90%). The least amount of tubular occlusion was shown by Thermoseal (86.12%). Conclusion: NovaMin-containing toothpaste, SHY-NM, showed maximum tubular occlusion and it appears to be a promising desensitizing dentifrice

Image_2_Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis.TIF

AimsTo explore the hepatoprotective role of quercetin and its novel molecular mechanism of action on breast cancer associated hepatic inflammation and fibrosis via Vitamin D receptor (VDR).Main methodsWe used Ehrlich Ascites Carcinoma (mouse mammary carcinoma) model for our in-vivo experiments and human breast cancer cell lines for in-vitro assays. We inoculated 1.5 × 106 Ehrlich ascites carcinoma cells into female Swiss albino mice. Quercetin (50 mg/kg) was administered intraperitoneally for 15 days. Liver enzymes activity was determined using a spectrophotometric assay. The hallmarks of inflammation and fibrosis were determined using Immunohistochemistry. The effect of quercetin on tumor formation was elucidated using human breast cancer cell lines and chick chorioallantoic membrane assay. Docking study was performed to explore the binding mode of quercetin with VDR.Key findingsIn EAC tumor-bearing mice, cell numbers, tumor volume, body weight and liver weight were dramatically increased, while they significantly decreased in mice treated with quercetin. Additionally, the peritoneal neo-angiogenesis was also significantly suppressed in the quercetin-treated mice, compared to the control. In addition, quercetin treated EAC tumor bearing mice had lower levels of liver enzymes, decreased hepatic inflammation and fibrosis compared with EAC tumor bearing mice. Docking study confirmed VDR-quercetin interaction. Furthermore, in-vitro assays and chick chorioallantoic membrane assay revealed the Vitamin D mimicking effect of quercetin.SignificanceDietary flavonoid, quercetin could act as a promising therapeutic drug to suppress the breast cancer induced tumor angiogenesis, hepatic inflammation, and fibrosis possibly via activation of VDR.</p

Image_1_Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis.TIF

AimsTo explore the hepatoprotective role of quercetin and its novel molecular mechanism of action on breast cancer associated hepatic inflammation and fibrosis via Vitamin D receptor (VDR).Main methodsWe used Ehrlich Ascites Carcinoma (mouse mammary carcinoma) model for our in-vivo experiments and human breast cancer cell lines for in-vitro assays. We inoculated 1.5 × 106 Ehrlich ascites carcinoma cells into female Swiss albino mice. Quercetin (50 mg/kg) was administered intraperitoneally for 15 days. Liver enzymes activity was determined using a spectrophotometric assay. The hallmarks of inflammation and fibrosis were determined using Immunohistochemistry. The effect of quercetin on tumor formation was elucidated using human breast cancer cell lines and chick chorioallantoic membrane assay. Docking study was performed to explore the binding mode of quercetin with VDR.Key findingsIn EAC tumor-bearing mice, cell numbers, tumor volume, body weight and liver weight were dramatically increased, while they significantly decreased in mice treated with quercetin. Additionally, the peritoneal neo-angiogenesis was also significantly suppressed in the quercetin-treated mice, compared to the control. In addition, quercetin treated EAC tumor bearing mice had lower levels of liver enzymes, decreased hepatic inflammation and fibrosis compared with EAC tumor bearing mice. Docking study confirmed VDR-quercetin interaction. Furthermore, in-vitro assays and chick chorioallantoic membrane assay revealed the Vitamin D mimicking effect of quercetin.SignificanceDietary flavonoid, quercetin could act as a promising therapeutic drug to suppress the breast cancer induced tumor angiogenesis, hepatic inflammation, and fibrosis possibly via activation of VDR.</p